Mithraprabhu, S., Perez-Suarez, T., Lim, S., Wong, D., Zhao, J., Bingham, N., Kerridge, I., Quach, H., Khong, T. T. F., Reynolds, J., Spencer, A. (2026). Circulating tumor DNA
                    <i>NRAS</i>
                    and
                    <i>TP53</i>
                    mutations to identify ultra-high-risk primary refractory myeloma patients.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.16_suppl.7557